Market news
TypeAll
SortNewest
Assets
ITRM
Iterum Therapeutics Provides Business Update
DUBLIN and CHICAGO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum” or “we”), a company focused on...
Aug 31Barchart.com
ITRM
Iterum Therapeutics Reports Third Quarter 2025 Financial Results
--Commercially Launched ORLYNVAH™ in the United States in August 2025-- --Extended Cash Runway into Q2 2026-- --Company to host conference call today at...
Aug 30Barchart.comITRM
Iterum Therapeutics Provides Business Update
Expanded Market Access for ORLYNVAHTM...
Aug 28Barchart.comITRM
This is the newest page. Registered accounts read further back.